304 related articles for article (PubMed ID: 29134827)
1. Serum, plasma and saliva biomarkers for head and neck cancer.
Arantes LMRB; De Carvalho AC; Melendez ME; Lopes Carvalho A
Expert Rev Mol Diagn; 2018 Jan; 18(1):85-112. PubMed ID: 29134827
[TBL] [Abstract][Full Text] [Related]
2. Cell-free nucleic acids in body fluids as biomarkers for the prediction and early detection of recurrent head and neck cancer: A systematic review of the literature.
van Ginkel JH; Slieker FJB; de Bree R; van Es RJJ; Van Cann EM; Willems SM
Oral Oncol; 2017 Dec; 75():8-15. PubMed ID: 29224828
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
4. Salivary epigenetic biomarkers in head and neck squamous cell carcinomas.
Lim Y; Sun CX; Tran P; Punyadeera C
Biomark Med; 2016; 10(3):301-13. PubMed ID: 26888346
[TBL] [Abstract][Full Text] [Related]
5. Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges.
Chantre-Justino M; Alves G; Delmonico L
Explor Target Antitumor Ther; 2022; 3(4):533-552. PubMed ID: 36071985
[TBL] [Abstract][Full Text] [Related]
6. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
[TBL] [Abstract][Full Text] [Related]
7. Salivary mRNA targets for cancer diagnostics.
Zimmermann BG; Wong DT
Oral Oncol; 2008 May; 44(5):425-9. PubMed ID: 18061522
[TBL] [Abstract][Full Text] [Related]
8. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer.
Mishra V; Singh A; Chen X; Rosenberg AJ; Pearson AT; Zhavoronkov A; Savage PA; Lingen MW; Agrawal N; Izumchenko E
Br J Cancer; 2022 Feb; 126(3):361-370. PubMed ID: 34876674
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of HPV-Positive Head and Neck Squamous Cell Carcinoma with Circulating and Salivary DNA Biomarkers.
Borsetto D; Cheng J; Payne K; Nankivell P; Batis N; Rao K; Bhide S; Li F; Kim Y; Mehanna H; Wong D
Crit Rev Oncog; 2018; 23(3-4):235-245. PubMed ID: 30311577
[TBL] [Abstract][Full Text] [Related]
10. Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring.
Diez-Fraile A; Ceulaer J; Derpoorter C; Spaas C; Backer T; Lamoral P; Abeloos J; Lammens T
Cells; 2020 Dec; 10(1):. PubMed ID: 33396240
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients.
Rettori MM; de Carvalho AC; Bomfim Longo AL; de Oliveira CZ; Kowalski LP; Carvalho AL; Vettore AL
Carcinogenesis; 2013 Jan; 34(1):20-7. PubMed ID: 23042095
[TBL] [Abstract][Full Text] [Related]
12. Letter to the editor: "Liquid biopsy based on saliva cell-free DNA as a potential biomarker for head and neck cancer".
Rapado-González Ó; Muinelo-Romay L; Suárez-Cunqueiro MM
Oral Oncol; 2021 Jan; 112():105016. PubMed ID: 32972862
[No Abstract] [Full Text] [Related]
13. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas.
Lee KD; Lee HS; Jeon CH
Anticancer Res; 2011 Apr; 31(4):1161-7. PubMed ID: 21508360
[TBL] [Abstract][Full Text] [Related]
14. Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection.
Pereira LH; Adebisi IN; Perez A; Wiebel M; Reis I; Duncan R; Goodwin WJ; Hu JJ; Lokeshwar VB; Franzmann EJ
Cancer Biomark; 2011; 10(5):241-9. PubMed ID: 22699785
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
[TBL] [Abstract][Full Text] [Related]
16. Liquid Biopsy in Head and Neck Cancer: Promises and Challenges.
Nonaka T; Wong DTW
J Dent Res; 2018 Jun; 97(6):701-708. PubMed ID: 29513618
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of head and neck squamous cell cancer biomarkers.
Polanska H; Raudenska M; Gumulec J; Sztalmachova M; Adam V; Kizek R; Masarik M
Oral Oncol; 2014 Mar; 50(3):168-77. PubMed ID: 24382422
[TBL] [Abstract][Full Text] [Related]
18. Saliva-based cell-free DNA and cell-free mitochondrial DNA in head and neck cancers have promising screening and early detection role.
Sayal L; Hamadah O; Almasri A; Idrees M; Thomson P; Kujan O
J Oral Pathol Med; 2023 Jan; 52(1):29-36. PubMed ID: 36459078
[TBL] [Abstract][Full Text] [Related]
19. Methylation as a biomarker for head and neck cancer.
Arantes LM; de Carvalho AC; Melendez ME; Carvalho AL; Goloni-Bertollo EM
Oral Oncol; 2014 Jun; 50(6):587-92. PubMed ID: 24656975
[TBL] [Abstract][Full Text] [Related]
20. Current trends in the etiology and diagnosis of HPV-related head and neck cancers.
Chai RC; Lambie D; Verma M; Punyadeera C
Cancer Med; 2015 Apr; 4(4):596-607. PubMed ID: 25644715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
